Immune Response to Coccidioidomycosis and the Development of a Vaccine
AbstractCoccidioidomycosis is a fungal infection caused by Coccidioides posadasii and Coccidioides immitis. It is estimated that 150,000 new infections occur in the United States each year. The incidence of this infection continues to rise in endemic regions. There is an urgent need for the development of better therapeutic drugs and a vaccine against coccidioidomycosis. This review discusses the features of host innate and adaptive immune responses to Coccidioides infection. The focus is on the recent advances in the immune response and host-pathogen interactions, including the recognition of spherules by the host and defining the signal pathways that guide the development of the adaptive T-cell response to Coccidioides infection. Also discussed is an update on progress in developing a vaccine against these fungal pathogens. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Castro-Lopez, N.; Hung, C.-Y. Immune Response to Coccidioidomycosis and the Development of a Vaccine. Microorganisms 2017, 5, 13.
Castro-Lopez N, Hung C-Y. Immune Response to Coccidioidomycosis and the Development of a Vaccine. Microorganisms. 2017; 5(1):13.Chicago/Turabian Style
Castro-Lopez, Natalia; Hung, Chiung-Yu. 2017. "Immune Response to Coccidioidomycosis and the Development of a Vaccine." Microorganisms 5, no. 1: 13.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.